The Executive Management team at Diurnal is responsible for steering the company's strategic direction and ensuring the successful development and commercialization of hormone therapeutics. Comprising key leaders such as the Chairman, Chief Scientific Officer, CEO & CFO, and Chief Business Officer, the team collaborates to align scientific innovation with business objectives, driving growth and delivering value to patients with rare and chronic endocrine conditions.
View all